Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA grants accelerated approval to Jemperli for dMMR endometrial cancer

April 23, 2021

Trodelvy gains accelerated approval in U.S. for advanced urothelial cancer

April 14, 2021

Toripalimab approved in China for locally advanced or metastatic urothelial carcinoma

April 13, 2021

Subcutaneous injection of Tysabri approved in Europe for relapsing-remitting MS

April 8, 2021

Trodelvy granted expanded approval by FDA for metastatic TNBC

April 8, 2021

FDA approves Qelbree for the treatment of ADHD in pediatric patients

April 6, 2021

FDA approves Vyxeos for secondary AML in pediatric patients

March 31, 2021

FDA approves Abecma for relapsed or refractory multiple myeloma

March 29, 2021

FDA approves Myrbetriq tablets and granules for neurogenic detrusor overactivity in children

March 26, 2021

Seikagaku obtains approval in Japan for Joyclu intra-articular injection

March 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...